BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22447917)

  • 1. Prognostic value of nuclear factor κ B expression in patients with advanced cervical cancer undergoing radiation therapy followed by hysterectomy.
    Baiocchi G; Begnami MD; Fukazawa EM; Oliveira RA; Faloppa CC; Kumagai LY; Badiglian-Filho L; Pellizzon AC; Maia MA; Jacinto AA; Soares FA; Lopes A
    J Clin Pathol; 2012 Jul; 65(7):614-8. PubMed ID: 22447917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
    Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis.
    Weichert W; Boehm M; Gekeler V; Bahra M; Langrehr J; Neuhaus P; Denkert C; Imre G; Weller C; Hofmann HP; Niesporek S; Jacob J; Dietel M; Scheidereit C; Kristiansen G
    Br J Cancer; 2007 Aug; 97(4):523-30. PubMed ID: 17622249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.
    Liu X; Wang B; Ma X; Guo Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):418-24. PubMed ID: 19395464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
    Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
    Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
    Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
    Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.
    Montagut C; Tusquets I; Ferrer B; Corominas JM; Bellosillo B; Campas C; Suarez M; Fabregat X; Campo E; Gascon P; Serrano S; Fernandez PL; Rovira A; Albanell J
    Endocr Relat Cancer; 2006 Jun; 13(2):607-16. PubMed ID: 16728586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy.
    Berardi R; Maccaroni E; Mandolesi A; Mantello G; Onofri A; Biscotti T; Pierantoni C; Siquini W; Marmorale C; Guerrieri M; Bearzi I; Cascinu S
    Dig Liver Dis; 2012 Jul; 44(7):617-22. PubMed ID: 22440241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should simple hysterectomy be added after chemo-radiation for stage IB2 and bulky IIA cervical carcinoma?
    Eitan R; Levavi H; Peled Y; Brenner R; Sabah G; Ben-Arie A; Dgani R; Fishman A; Sulkes A; Fenig E; Koren C
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):289-93. PubMed ID: 20618249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
    Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
    Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of failures and clinical outcome of patients with locally advanced cervical cancer treated with a tailored integrated therapeutic approach.
    Gadducci A; Fabrini MG; Perrone F; Manfredi B; Fanucchi A; Laliscia C; Barsotti C; Scotti V; Genazzani AR; Greco C
    Anticancer Res; 2010 Sep; 30(9):3731-5. PubMed ID: 20944162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in cervix cancer patients treated with radiotherapy followed by radical surgery.
    Rouzier R; Morice P; De Crevoisier R; Pomel C; Rey A; Bonnet K; Recoules-Arche A; Duvillard P; Lhomme C; Haie-Meder C; Castaigne D
    Eur J Surg Oncol; 2005 May; 31(4):424-33. PubMed ID: 15837052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy results for patients undergoing inappropriate surgery in the presence of invasive cervical carcinoma.
    Choi DH; Huh SJ; Nam KH
    Gynecol Oncol; 1997 Jun; 65(3):506-11. PubMed ID: 9190983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z; Ma J; Li N; Sun N; Wang C
    Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
    Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY
    J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiation.
    Garg AK; Jhingran A; Klopp AH; Aggarwal BB; Kunnumakkara AB; Broadus RR; Eifel PJ; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1331-6. PubMed ID: 20231067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer.
    Mabuchi S; Okazawa M; Isohashi F; Matsuo K; Ohta Y; Suzuki O; Yoshioka Y; Enomoto T; Kamiura S; Kimura T
    Gynecol Oncol; 2011 Nov; 123(2):241-7. PubMed ID: 21820708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of constitutive nuclear factor-kappaB activation with aggressive aspects and poor prognosis in cervical cancer.
    Li J; Jia H; Xie L; Wang X; Wang X; He H; Lin Y; Hu L
    Int J Gynecol Cancer; 2009 Nov; 19(8):1421-6. PubMed ID: 20009901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications.
    Espinosa I; Briones J; Bordes R; Brunet S; Martino R; Sureda A; Sierra J; Prat J
    Histopathology; 2008 Oct; 53(4):441-9. PubMed ID: 18983609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.
    Sugiyama T; Nishida T; Hasuo Y; Fujiyoshi K; Yakushiji M
    Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.